Hinge Health, Inc. (HNGE) vs Insulet Corp. (PODD)
A side-by-side comparison of Hinge Health, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.
HNGE
Hinge Health, Inc.
$97.67HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
PODD
Insulet Corp.
$131.69HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — HNGE vs PODD
growth of $100 · dividends reinvested · last 1yHNGE +160.0% (+160.0%/yr)PODD -59.0% (-59.0%/yr)HNGE compounded faster over this window
Log scale — wide-divergence pair
HNGE PODD
HNGE vs PODD: by the numbers
- •PODD is the larger company ($9.12B vs $7.56B market cap).
- •PODD trades at the lower trailing earnings multiple (24.61 vs 75.91 P/E), one valuation lens rather than an overall verdict.
- •HNGE converts more revenue to profit (15.15% vs 12.29% net margin).
Metrics side by side
Valuation
| Metric | HNGE | PODD |
|---|---|---|
| P/E ratio | 75.91 | 24.61 |
| Forward P/E | 42.12 | 20.25 |
| PEG ratio | N/A | 0.24 |
| P/S ratio | 10.50 | 2.99 |
| P/B ratio | 21.95 | 6.41 |
| EV / EBITDA | 74.49 | 15.35 |
| FCF yield | 3.80% | 3.27% |
Profitability
| Metric | HNGE | PODD |
|---|---|---|
| Gross margin | 84.52% | 71.08% |
| Operating margin | -92.94% | 16.89% |
| Net margin | 15.15% | 12.29% |
| ROE | 31.68% | 26.39% |
| ROIC | 26.62% | 16.04% |
Growth (annualized)
| Metric | HNGE | PODD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 25.13% |
| EPS CAGR (5Y) | N/A | 99.91% |
| Total return CAGR (5Y) | N/A | -14.32% |
Frequently asked
- Which has the lower trailing P/E, HNGE or PODD?
- PODD has the lower trailing P/E: HNGE trades at 75.91 and PODD at 24.61. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is HNGE or PODD more profitable?
- HNGE runs the higher net margin — HNGE at 15.15% versus PODD at 12.29%.
Go deeper
Dig into the metrics
Hinge Health P/E ratioInsulet P/E ratioHinge Health ROEInsulet ROEHinge Health operating marginInsulet operating marginHinge Health revenue growthInsulet revenue growthHinge Health free cash flowInsulet free cash flow
Hinge Health & Insulet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.